Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Jan 29, 2021 10:00 AM - Jan 29, 2021 6:30 PM

8th DIA Cardiac Safety Workshop in Japan

[Session 2]Clinical / ECG

Session Chair(s)

Atsushi  Sugiyama, MD, PhD

Atsushi Sugiyama, MD, PhD

Professor and Chairman, Department of Pharmacology

Toho University Faculty of Medicine, Japan

Kyosuke  Takeshita, MD, PhD

Kyosuke Takeshita, MD, PhD

Department of Clinical Laboratory Medicine

Saitama Medical Center, Saitama Medical University, Japan

Speaker(s)

Börje C. Darpö, MD, PhD

Replacing the Thorough QT study with Concentration-QTc analysis applied to First-in-Human studies – recent trends and experience from interactions with regulators

Börje C. Darpö, MD, PhD

Clario, Sweden

Chief Scientific Officer, Cardiac Safety

Kaori  Shinagawa, MD, PhD

Current status and future perspective of clinical proarrhythmic risk assessment from a regulatory point of view

Kaori Shinagawa, MD, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Senior Scientist for Clinical Medicine, Office of New Drug II

Jorg  Taubel, MD, FFPM

Reasons why it is difficult to evaluate cardiac safety for antidiabetic drugs - Findings obtained in a type 1 diabetes study examining the effects of diet on normal and insulin-deficient subjects

Jorg Taubel, MD, FFPM

Richmond Pharmacology, United Kingdom

Chief Executive Officer

Boaz  Mendzelevski, MD

Boaz Mendzelevski, MD

Cardiac Safety Consultants Ltd., United Kingdom

Consultant Cardiologist

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.